Dr. Flannery is Director of Telegenetics and Digital Genetics at Cleveland Clinic, where his team is creating the digital future of genetic services using synchronous telemedicine, eConsults and chatbots. From February 2014 to May 2018 he served as Medical Director of the American College of Medical Genetics and Genomics and also served as Medical Director of the NICHD funded Newborn Screening Translational Research Network and was Medical Director of the HRSA funded National Coordinating Center for Regional Genetic Services Networks, and serve on its Telegenetics Workgroup. Prior to ACMG he was at the Medical College of Georgia (now Augusta University) where he served in a succession of clinical, academic and medical staff leadership positions. He has been a grant reviewer for NIH, NHGRI, FDA, U.S. Army, professional organizations, and state commissions. Dr. Flannery is known as a pioneer in telemedicine. At MCG he started telemedicine genetics clinics in 1995, which are considered to have been the longest continually running telegenetics services in the nation. He has served on the boards of directors of multiple telehealth entities. He publishes extensively and is a frequent presenter at national meetings. He has served on national committees/workgroups including the Telehealth Committee of the National Quality Forum and the Digital Medicine Payment Advisory Group for the American Medical Association, and currently serves on the Medicare Evidence Development and Coverage .Advisory Committee for CMS.